Formyl-Peptide Receptor Agonists and Amorphous SiO(2)-NPs Synergistically and Selectively Increase the Inflammatory Responses of Human Monocytes and PMNs

We tested whether amorphous SiO(2)-NPs and formylpeptide receptor (FPRs) agonists synergistically activate human monocytes and neutrophil polymorphonuclear granulocytes (PMNs). Peptide ligands specifically binding to FPR1 (f-MLP) and to FPR2 (MMK-1, WKYMVM and WKYMVm) human isoforms did not modify t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavano, Regina, Segat, Daniela, Fedeli, Chiara, Malachin, Giulia, Lubian, Elisa, Mancin, Fabrizio, Papini, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Nanobiomedicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998267/
https://www.ncbi.nlm.nih.gov/pubmed/29942377
http://dx.doi.org/10.5772/62251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998267/
https://www.ncbi.nlm.nih.gov/pubmed/29942377
http://dx.doi.org/10.5772/62251

Ejemplares similares